Treat to Target of NO NEW FRACTURES. How do we find that target? DXA >-2.5 is a start. Fragility fractures increase new fracture risk. FRAX adds many more risk factors to the...
Our goal is NO NEW FRACTURES. Cancellous (spongy, like the ends of the drumstick) bone should be a strong latticework of struts called trabeculi. Clinical Osteoporosis, an increased fracture risk,...
Our Target is NO NEW FRACTURES. The original goal by DXA was a T-score of -2.4 or better. But age is a huge factor in actual fracture risk. The fracture risk...
Treat to Target means aiming for NO NEW FRACTURES. As discussed last time, the original target was to maintain Bone Mineral Density (BMD) at the level first tested. 25 years...
The FDA approved Tymlos (Abaloparatide) in June for use in women diagnosed with osteoporosis. Unfortunately most patients are unlikely to obtain insurance coverage for Tymlos until January or February 2018. Tymlos...
Treat to Target has been standard for chronic diseases like high blood pressure and diabetes for decades. These are chronic diseases, more common as we get older, that we can control...
University of Wisconsin hosts biennially the Bare Bones of Osteoporosis Care Symposium. This year the Wisconsin Bone Club followed the symposium. Felicia Cosman, MD from Helen Hayes in New York was the guest...
As we enter Memorial Day Weekend, let us remember those who have served in times of war, declared and undeclared. Evil exists in our world. Those who survived the fight against the...
May is National Osteoporosis Month. That should be National Osteoporosis Prevention Month. Or perhaps National Bone Health Optimization Month. Click on the helpful link to National Osteoporosis Foundation to learn...
Clinical Osteoporosis 2017, NOF and ISCD joint meeting had a different emphasis this year. Fracture Risk, rather than Bone Mineral Density (BMD) is now the key metric. Several speakers emphasizd...